Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes

被引：79

作者：

von Bibra, H

Hansen, A

Dounis, V

Bystedt, T

Malmberg, K

Rydén, L

机构：

[1] Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden

[2] Karolinska Hosp, Dept Endocrinol, S-10401 Stockholm, Sweden

来源：

HEART | 2004年 / 90卷 / 12期

关键词：

D O I：

10.1136/hrt.2003.020842

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1483 / 1484

页数：2

共 5 条

[1] C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes [J].

Hansen, A ;

Johansson, BL ;

Wahren, J ;

von Bibra, H .

DIABETES, 2002, 51 (10) :3077-3082

[2] Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease [J].

Rask-Madsen, C ;

Ihlemann, N ;

Krarup, T ;

Christiansen, E ;

Kober, L ;

Kistorp, CN ;

Torp-Pedersen, C .

DIABETES, 2001, 50 (11) :2611-2618

[3] Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow [J].

Vincent, MA ;

Dawson, D ;

Clark, ADH ;

Lindner, JR ;

Rattigan, S ;

Clark, MG ;

Barrett, EJ .

DIABETES, 2002, 51 (01) :42-48

[4]

von Bibra H, 2002, Eur J Echocardiogr, V3, P271, DOI 10.1053/euje.2002.0166

[5]

Wei K, 1998, CIRCULATION, V97, P473

← 1 →